SCHEMBL6848713

SCHEMBL6848713

CCc1ccc(CCNS(=O)(=O)c2cccc3ccccc23)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 2/20 0.58
CYP3A4 P08684 3/20 0.56
SCN1A P35498 2/20 0.56
SCN2A Q99250 2/20 0.56
SCN3A Q9NY46 2/20 0.56
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
HSD17B10 Q99714 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.52
KMT2A Q03164 2/20 0.49
SLC6A9 P48067 1/20 0.47
NPY5R Q15761 2/20 0.47
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NQO2 P16083 1/20 0.47
FLT3 P36888 1/20 0.47
TPSAB1 Q15661 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3701345 0.88 NSD2 (0.72) NSD2CYP3A4SCN1ASCN2ASCN3A
SCHEMBL10453019 0.83 NSD2 (0.58) NSD2CYP3A4SCN1ASCN2ASCN3A
SCHEMBL3680789 0.82 CYP3A4 (0.64) CYP3A4SCN1ASCN2ASCN3AKDM4E
SCHEMBL14919628 0.81 NSD2 (0.83) NSD2CYP3A4KDM4EALDH1A1CYP1A2
SCHEMBL3698543 0.80 CYP3A4 (0.69) CYP3A4SCN1ASCN2ASCN3AKDM4E
SCHEMBL2878189 0.79 SCN1A (0.59) CYP3A4SCN1ASCN2ASCN3AKDM4E
SCHEMBL11361752 0.79 NPY5R (0.51) NSD2ALDH1A1SMN1; SMN2NPY5R
SCHEMBL27488281 0.78 CYP1A2 (0.72) CYP3A4SCN1ASCN2ASCN3AKDM4E
SCHEMBL11107112 0.78 HDAC1 (0.53) NSD2CYP3A4SCN1ASCN2ASCN3A
SCHEMBL11107108 0.78 HDAC1 (0.53) NSD2CYP3A4SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011111880-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DISEASES CAUSED BY THE NUCLEAR EXPORT OF GSK3, INCLUDING A COMPOUND FOR INHIBITING THE NUCLEAR EXPORT OF GSK3 주식회사 메디젠텍 (KR) 2011-09-15 WO disclosed